Angelini Pharma
Manufacturing · Italy · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Viale Amelia 70, Rome, Latium, 00181, It...Phone Number
+39 6780531Website
www.angelinipharma.comRevenue
$766.7 MillionIndustry
About Angelini Pharma
Angelini Pharma Org Chart
Is Angelini Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Angelini Pharma had a recent Job posting/layoffs
Product Launch: Get notified when Angelini Pharma launches new products
Check if Angelini Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Angelini Pharma recently announced quarterly report
Angelini Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Angelini Pharma is spiking on competitors!
Funding: Get notified immidiatlly once Angelini Pharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Angelini Pharma
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Angelini Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Angelini Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Angelini Pharma.
Angelini Pharma Tech Stack
A closer look at the technologies used by Angelini Pharma
Most Recent Scoops
Angelini Pharma News & Media
Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO
Angelini Pharma today announced the appointment of Sergio Marullo di Condojanni as Chief Executive Officer.Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health AssGRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside North America
GRIN also announces closing of $140 million Series D financing, including a $65 million strategic equity investment from Angelini Pharma and $75 million from existing investor Blackstone Life Sciences Collaboration combines Angelini Pharma's global reach and focus on complex neurological...GRIN Therapeutics and Angelini Pharma Enter into Exclusive Collaboration to Develop and Commercialize Radiprodil Outside North America
GRIN also announces closing of $140 million Series D financing, including a $65 million strategic equity investment from Angelini Pharma and $75 million from existing investor Blackstone Life Sciences Collaboration combines Angelini Pharma's global reach and focus on complex neurological...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Angelini Pharma
Angelini is a pharmaceutical company committed to helping patients with a constant and prevalent focus on mental health. The company was established in 1919 and is headquartered out of Rome, Italy.... Read More